D
Telix Pharmaceuticals Limited TLX
$9.08 -$0.28-2.99% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Net Income -65.50% -4.07% 971.69% 329.12% 200.69%
Total Depreciation and Amortization 162.04% 104.70% 18.20% 20.18% 20.66%
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items 158.77% 208.33% 0.25% -29.44% -56.72%
Change in Net Operating Assets -94.04% -94.04% -94.04% -187.14% -3,140.78%
Cash from Operations -32.64% 75.46% 63.48% 151.92% 373.77%
Capital Expenditure -76.10% -63.44% -47.20% -46.80% -43.33%
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -1,327.32% -14,161.52% -2,292.06% -2,509.49% -2,813.53%
Divestitures -- -- -- -- --
Other Investing Activities -220.60% -367.16% -507.21% -735.55% -126,176.65%
Cash from Investing -604.67% -892.22% -434.60% -503.09% -684.40%
Total Debt Issued 11,865.38% 11,810.22% 11,286.82% 5,772.44% -0.70%
Total Debt Repaid -141.43% -138.08% -23.13% -33.21% -47.59%
Issuance of Common Stock -75.20% -83.25% -87.38% -55.03% -7.71%
Repurchase of Common Stock -- -- -- -- --
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -1,483.07% -360.15% -- -- --
Cash from Financing 8,225.78% 9,294.13% 6,152.79% 3,386.35% -12.12%
Foreign Exchange rate Adjustments 4,048.45% 11,929.52% 2,653.06% 2,232.35% -413.89%
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash 1,559.82% 25,942.45% 7,904.42% 3,344.30% -275.95%